Microcirculation
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Three high population screening microcirculation mildly abnormal, moderately abnormal patients.(Of Microcirculation Points at 2-8 between the patients); 2. 18-60 years of age, male or female; 3. Voluntary participation in the trial, and signed informed consent.
Exclusion criteria
Exclusion criteria: 1. Normal microcirculation, generally normal or severe abnormalities of patients; 2. Skin injury healed, bleeding tendencies, surgery or serious trauma stress situation; 3. Patients with severe hypertension [systolic blood pressure >=24KPa (180mmHg) and / or diastolic blood pressure >= 14KPa (105mmHg); 4. Implanted metal objects implanted medical electronic equipment, such as pacemakers and other persons; 5. With severe primary cardiac, liver, lung, kidney, blood, or affect the survival of serious diseases, such as cancer or AIDS; renal dysfunction; 6. Severe hypoproteinemia and serious systemic infection; 7. Mental disorders can not give fully informed consent; 8. Suspect or does have a history of alcohol and drug abuse; 9. According to the investigator's judgment, could easily lead to loss to follow to reduce the possibility of inclusion or so into the complex set of other lesions, such as working conditions change frequently; 10. Pregnancy, breast-feeding women; 11. Allergies, such as two or more drugs or a history of food allergies, or known allergy to the product used in the trial; 12. Participated in other clinical trials within three months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Microcirculation check point; | — |
Secondary
| Measure | Time frame |
|---|---|
| Pipe loop shape integral;State points of the blood flow;Loop weeks state point; | — |
Countries
China